LUXEMBOURG, Aug. 14, 2014 /PRNewswire/ -- ConvaTec today announced that it will hold an analyst and investor call to discuss 2014 second quarter results on Tuesday, August 19, 2014. Ken Berger, CEO, and Nigel Clerkin, CFO, will host the call at 9:00 AM ET live via telephone.
To participate in the conference call within the U.S. and Canada, dial (877) 366-0267.
To participate in the conference call outside the U.S. and Canada, dial (760) 666-3086.
The conference ID is 88736401.
Participants should dial in 10 minutes prior to the start of the call. The Company's 2014 Second Quarter Report will be available on the Company's website prior to the call under the Investors tab at www.convateccorporate.com.
For more information, please contact email@example.com.
ConvaTec is a global medical products and technologies company, with leading market positions in wound therapeutics, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. ConvaTec has over 8,000 employees, with 11 manufacturing sites in 8 countries, and we do business in more than 100 countries. We are owned by Nordic Capital and Avista Capital Partners. More information is available at www.convatec.com.
Senior Vice President